Five years on, biosimilars need support from all health care players - STAT

Five years on, biosimilars need support from all health care players - STAT

Opinion: Five years on, biosimilars need support from all health care players

By SEAN MCGOWAN

SANDOZ, A DIVISION OF NOVARTIS

The FDA approved the first biosimilar five years ago, on March 6, 2015. Although the initial going was slow, biosimilars are now poised to make their mark.

READ MORE